Literature DB >> 20024490

Protective effect of ischaemic preconditioning on ischaemia/reperfusion-induced microvascular obstruction determined by on-line measurements of coronary pressure and blood flow in pigs.

A Posa1, N Pavo, R Hemetsberger, C Csonka, T Csont, P Ferdinandy, Z Petrási, C Varga, I J Pavo, F Laszlo, K Huber, M Gyöngyösi.   

Abstract

We investigated the protective effect of ischaemic preconditioning (IP) on the maintenance of coronary patency using on-line measurements of coronary pressures and blood flow in a closed-chest reperfused acute myocardial infarction (MI) model in pigs. Catheter-based 90-min occlusion followed by 60-min reperfusion of the left anterior descending coronary artery (LAD) was performed in anesthetised pigs (MI group). IP was applied (IP group) through two cycles of 5-min occlusion and 5-min reperfusion of the LAD before MI induction. Coronary patency was determined by measurements of coronary wedge pressure, collateral fractional flow reserve (FFRcoll), collateral pressure index (CPI) and absolute coronary blood flow (CBF). Inducible and constitutive nitric oxide synthase (iNOS/cNOS) activities and expressions were determined in the myocardium. Plasma levels of myeloperoxidase (MPO, index of activated leukocytes) and mean platelet volume (MPV, index of activated platelets) were measured. IP resulted in significantly lower levels of MPO (0.52 +/- 0.19 vs. 1.05 +/- 0.24 U/l, p<0.001) and MPV (9.1 +/- 0.6 vs. 9.6 +/- 1.0 fl, p=0.04), higher FFRcoll (0.17 +/- 0.05 vs. 0.04 +/- 0.05, p<0.001), CPI (0.13 +/- 0.05 vs. 0.02 +/- 0.05, p<0.001) and CBF (70.7 +/- 4.2 vs. 50.8 +/- 4.8 m/min, p<0.001) post-reperfusion as compared with the MI group. IP resulted in significantly higher cNOS activity and eNOS expression. Significant negative correlation was found between MPO and measures of coronary patency (FFRcoll, CPI and CBF) and cNOS activity. Moreover, cNOS activity correlated significantly with FFRcoll, CPI and CBF. In conclusion, IP attenuates the release of MPO and platelet activation, thereby contributing to the maintenance of vessel patency at microvascular level after reperfusion of the infarct-related artery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20024490     DOI: 10.1160/TH09-03-0165

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  5 in total

1.  Cardioprotective Effect of Selective Estrogen Receptor Modulator Raloxifene Are Mediated by Heme Oxygenase in Estrogen-Deficient Rat.

Authors:  Anikó Posa; Renáta Szabó; Krisztina Kupai; Anikó Magyariné Berkó; Médea Veszelka; Gergő Szűcs; Denise Börzsei; Mariann Gyöngyösi; Imre Pávó; Zoltán Deim; Zoltán Szilvássy; Béla Juhász; Csaba Varga
Journal:  Oxid Med Cell Longev       Date:  2017-07-09       Impact factor: 6.543

2.  Adverse impact of diet-induced hypercholesterolemia on cardiovascular tissue homeostasis in a rabbit model: time-dependent changes in cardiac parameters.

Authors:  Attila Kertész; Mariann Bombicz; Daniel Priksz; Jozsef Balla; Gyorgy Balla; Rudolf Gesztelyi; Balazs Varga; David D Haines; Arpad Tosaki; Bela Juhasz
Journal:  Int J Mol Sci       Date:  2013-09-17       Impact factor: 5.923

3.  The Value of Pre-Infarction Angina and Plasma D-Dimer in Predicting No-Reflow After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Acute Myocardial Infarction Patients.

Authors:  Hongyu Zhang; Baohua Qiu; Yan Zhang; Yanjun Cao; Xia Zhang; Zhiguo Wu; Shujing Wang; Lianlian Mei
Journal:  Med Sci Monit       Date:  2018-07-01

4.  Protective effect of puerarin against burn-induced heart injury in rats.

Authors:  Junling Liu; Jianyun Liu; Mingming Bai; Hui Wang
Journal:  Exp Ther Med       Date:  2020-04-29       Impact factor: 2.447

5.  Prognostic value of different cardiac magnetic resonance imaging derived parameters in Egyptian patients with ST-elevation myocardial infarction after successful reperfusion by primary percutaneous intervention.

Authors:  Diaa Kamal; Ahmed S Ibrahim; Merhan Ahmed Nasr; Sherihan S Madkour
Journal:  Egypt Heart J       Date:  2019-12-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.